This is progesterone receptor (PR) positivity in a breast carcinoma. The usefulness of this determination is not as well established as for estrogen receptors. The appearance of PR positivity is similar to that of ER staining with immunohistochemical techniques. Carcinomas that are PR positive, but not ER positive, may have a worse prognosis.